secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2024-02-06T23:59:59+00:00
Accession:  0001157523-24-000176
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q4 net sales $221M, EPS $0.87; FY2023 sales -8%; FY2024 guidance $850-920M
--------------------------------------------------------------------------------

- Q4 net sales $221M (-3% YoY, +4% seq); diluted EPS $0.87 (+32% YoY).
- FY2023 net sales $921M (-8% YoY); diluted EPS $3.30 (-8% YoY).
- FY2024 guidance: net sales $850-920M, diluted EPS $2.40-3.00, down from FY2023.
- Greater China active customers +5% YoY, +11% seq; North Asia net sales -10% YoY.
- No share repurchases in Q4; $71M remaining authorization; cash $330M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000115752324000176/0001157523-24-000176-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000115752324000176/a53892955.htm
  HTML page:      https://secwatch.observer/filing/0001157523-24-000176

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer